Amarin Corp Plc (AMRN)

[HDGabor]

P-

Nothing is wrong opposite (negative) opinion ... if it is (at least) logical ...

Impossible to list everything, so it will be just few example:
- you could not separate FDA approach from FDA sponsored / supported) publication regarding ARR
- it looks like you do not have a clue about R-IT (mean TG below 200 and high LDL.C acc. to you)
- all patients in R-IT wre advised perfectly ... yes, if the health systems are the same in the US and (e.g.) in Ukraine ...
- refer to MARINE / ANCHOR / JELIS data full with mistakes ... e.g. meanwhile M EPA baseline level was higher (app. 2 times than A) it was still app. 50% of JELIS
- meanwhile you could find one "relevant" study only, you do not think that try to figure out (not modelling!) R-IT event rate is waste of time ...
- Because you think the final p-value will be worse than p=0.17, you don't think the RRR will be better than 5% ... what? ... you have a strong opinion about p, but not about event rates ... Furthermore p determines RRR acc. to you ...
- You could not find anything about CHERRY trial other than AMRN's PR, so it was sponsored by Amarin ...

and the list could be continued. Your argument does not have any basis sometimes or controversial with your previous argument *e.g. JELIS is useless .... unless if you could pick up something to back up your word).

I agree with you that real investor could not be influenced by FUD / board post (so I do not think you have an agenda), but if you have ... please, do us a favor: invest in some times, check / learn the topic, make notes and be / stay consistent.

Again: Personally I more than welcome opposite / negative view, but please, include some value (starting with basic knowledge about Amarin and R-IT).

Best,
G